文献速递预防保健、筛查与疫苗慢病管理

结直肠癌筛查与预防

Colorectal Cancer Screening and Prevention.
PubMed 文献 · Am Fam Physician · 2025-01-01

本文综述美国结直肠癌流行病学趋势、筛查推荐与预防措施。美国预防服务工作组推荐平均风险且无症状成人45至75岁定期筛查;有腺瘤性息肉、炎症性肠病、腹部/盆腔放疗史、遗传易感疾病或一级亲属结直肠癌/腺瘤性息肉者应考虑更早开始筛查或监测。推荐筛查方式包括粪便免疫化学检测(可含DNA分析)及CT结肠成像、软式乙状结肠镜或结肠镜直接可视化;血液检测灵敏度低、成本高,仅作为患者拒绝所有一线检测时的二线选择。

要点

  • 平均风险无症状成人45至75岁应定期筛查结直肠癌。
  • 有腺瘤性息肉、炎症性肠病、腹盆腔放疗史、遗传易感或一级亲属史者考虑更早筛查。
  • 血液检测灵敏度低、成本高,仅作二线筛查选择。

核心结论

  • 定期筛查是预防结直肠癌的有力工具,应强调可改变的危险因素。

研究设计与样本

  • 本文为综述,汇总美国结直肠癌流行病学、筛查推荐与预防措施。

主要发现

  • 美国结直肠癌是第三常见诊断癌症和第二常见癌症死因,年发病率自1980年代以来下降。
  • 过去25年40至49岁成人发病率虽低但增加了15%。

关键数值与推荐

  • 美国预防服务工作组推荐平均风险且无结直肠癌症状体征的成人45至75岁定期筛查。
  • 有腺瘤性息肉或炎症性肠病既往诊断、腹部或盆腔放疗史、遗传易感疾病或一级亲属结直肠癌/腺瘤性息肉者应考虑更早开始筛查或监测。
  • 推荐筛查方式包括粪便免疫化学检测(可含DNA分析)及CT结肠成像、软式乙状结肠镜或结肠镜直接可视化。
  • 血液检测灵敏度低、成本高,仅当患者拒绝所有一线检测时作为二线筛查选择。

临床怎么用

  • 对平均风险无症状成人45至75岁定期筛查,高危者考虑更早开始。
  • 优先选择粪便免疫化学检测或直接可视化筛查,血液检测仅作二线。
  • 强调保持健康体重、中高强度体力活动、高果蔬全谷物低红肉加工肉饮食、不饮酒不吸烟。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In the United States, colorectal cancer is the third most commonly diagnosed cancer and the second most common cause of cancer death. The annual incidence has decreased since the 1980s. However, in the past 25 years, the incidence in adults 40 to 49 years of age, although low, has increased by 15%. The US Preventive Services Task Force recommends that adults with average risk and no signs or symptoms of colorectal cancer undergo periodic screening from 45 to 75 years of age. Starting screening or surveillance at an earlier age should be considered in patients with a prior diagnosis of adenomatous polyps or inflammatory bowel disease, a history of radiation to the abdomen or pelvis to treat a prior cancer, any genetic disorder that predisposes the patient to a high lifetime risk of cancer, or a first-degree relative with colorectal cancer or adenomatous polyps. Recommended screening modalities include stool-based fecal immunochemical tests, which can also include DNA analysis, and direct visualization via computed tomography colonography, flexible sigmoidoscopy, or colonoscopy. Blood-based testing has low sensitivity and high cost and is therefore a second-line screening option performed only when the patient declines all first-line tests. Physicians should emphasize to patients that regular screening is a powerful tool for preventing colorectal cancer and highlight modifiable risk factors, which include staying at a healthy weight; performing moderate to vigorous physical activity; eating a diet high in fruits, vegetables, and whole grains and low in red and processed meats; not drinking alcohol; and not smoking.

来源:Am Fam Physician,查看原文。版权归原作者所有。

引用

  1. Sur DKC, Brown PC. Colorectal Cancer Screening and Prevention. Am Fam Physician. 2025. PMID: 40961305

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。